Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q1 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.